Orvepitant
Orvepitant is a drug that is used in the treatment of depression and anxiety. It is a neurokinin 1 receptor antagonist, which means it works by blocking the action of a chemical in the brain called substance P. This chemical is involved in transmitting pain signals to the brain, and by blocking its action, orvepitant can help to reduce feelings of pain and discomfort.
Orvepitant was developed by the pharmaceutical company GlaxoSmithKline, and it is currently in the late stages of clinical trials. It has shown promise in treating a variety of conditions, including major depressive disorder, generalized anxiety disorder, and post-traumatic stress disorder.
Mechanism of Action[edit | edit source]
Orvepitant works by blocking the action of substance P, a chemical in the brain that is involved in transmitting pain signals. Substance P is a neuropeptide, which means it is a small protein-like molecule used by nerve cells to communicate with each other. It is found in high concentrations in the brain and spinal cord, and it is involved in many bodily functions, including pain perception and the regulation of mood.
By blocking the action of substance P, orvepitant can help to reduce feelings of pain and discomfort. This makes it potentially useful in treating a variety of conditions, including depression, anxiety, and post-traumatic stress disorder.
Clinical Trials[edit | edit source]
Orvepitant is currently in the late stages of clinical trials. These trials are designed to test the safety and effectiveness of the drug in treating various conditions. So far, the results have been promising. In studies of patients with major depressive disorder, orvepitant has been shown to significantly reduce symptoms compared to a placebo. Similar results have been seen in studies of patients with generalized anxiety disorder and post-traumatic stress disorder.
Side Effects[edit | edit source]
Like all drugs, orvepitant can cause side effects. The most common side effects reported in clinical trials include nausea, vomiting, and dizziness. Less common side effects include headache, insomnia, and diarrhea. In most cases, these side effects are mild and go away on their own without treatment.
See Also[edit | edit source]
- Neurokinin 1 receptor antagonists
- Substance P
- Major depressive disorder
- Generalized anxiety disorder
- Post-traumatic stress disorder
| Orvepitant Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
